CRISPR Therapeutics AG - Common Stock (CRSP)

44 filings reported holding CRSP - CRISPR Therapeutics AG - Common Stock as of Q2 2017.
CRISPR Therapeutics AG - Common Stock (CRSP) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,694,198 shares of 90,438,636 outstanding shares and own 10.72% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (3,220,728 shares), Abingworth LLP (2,444,809 shares), CLOUGH CAPITAL PARTNERS L P (797,231 shares), MORGAN STANLEY (747,722 shares), FRANKLIN RESOURCES INC (729,333 shares), New Leaf Venture Partners, L.L.C. (527,730 shares), ORBIMED ADVISORS LLC (372,191 shares), Novo Holdings A/S (223,317 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (173,907 shares), and Vivo Capital, LLC (148,878 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.